U.S. General Merchandise and Department Stores Stock News

Zebra Technologies has delivered a share price that is still down sharply over five years, yet its Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside from current levels, while market multiples look closer to fair. The stock has declined 51.3% over the past five years, which sets a cautious backdrop for any case that it is now undervalued. Fresh product launches in high-speed machine vision can support long term growth expectations, but the valuation still faces...

MGIC Investment (MTG) has drawn fresh attention after recent share price gains of 4.7% over the past week and 12.3% over the past month, prompting investors to reassess the mortgage insurer’s current valuation. See our latest analysis for MGIC Investment. Set against a 1 year total shareholder return of 19.58% and a 5 year total shareholder return of 143.64%, MGIC Investment’s recent share price strength suggests momentum has been building as investors reassess the balance between earnings,...

First Citizens BancShares (FCNC.A) is drawing attention as investors position ahead of its upcoming quarterly earnings report, with recent commentary highlighting a history of earnings surprises and a currently favorable Earnings ESP signal. See our latest analysis for First Citizens BancShares. First Citizens BancShares’ share price has edged higher over the past week and quarter, while the year to date share price return is slightly down and the 1 year total shareholder return is broadly...

Fabrinet’s share price has delivered very strong 5 year gains, yet its valuation signals are pulling in different directions, with the intrinsic value estimate pointing to a premium while earnings based multiples suggest the stock screens as cheap. Fabrinet has returned 418.7% over 5 years, setting a high bar for what investors may expect from the stock at today’s price. Expectations for continued cash generation can support the current valuation, but any disappointment in future revenue or...

Papa John’s recently reported softer-than-expected earnings and lower revenue, raising fresh questions about customer demand, restaurant traffic, and how effectively the company is managing its costs. These results shift attention to whether improvements in franchise economics, digital engagement, and tighter expense control can help Papa John’s regain operational momentum. Next, we’ll examine how weaker earnings and revenue, and the questions they raise about operating efficiency, may...

Earlier this year, Velvæ re Park City named Christie's International Real Estate, which operates under Compass, as the exclusive sales and marketing brokerage for its luxury residences and estate homesites in Deer Valley's East Village. This agreement gives Compass access to a high-profile mountain luxury development while tapping Christie's global network to attract affluent international buyers. Next, we will examine how exclusive access to this luxury Park City project could influence...

Kadant (KAI) is back in focus after fresh analysis flagged slowing revenue growth, flat earnings per share, and weakening returns on capital. This is prompting investors to reassess how durable its existing profit engines may be. See our latest analysis for Kadant. Kadant's share price is at US$311.01 after a 7 day share price return of 5.56%. However, momentum has faded over 90 days, with the share price down 6.28%, even as the 5 year total shareholder return sits at 79.44%. If Kadant's...

We wouldn't blame Braze, Inc. ( NASDAQ:BRZE ) shareholders if they were a little worried about the fact that Astha...

Leonardo DRS, Inc. recently announced it signed a blanket purchase agreement to supply more than 50,000 Tenum Orbit thermal imaging cameras, supporting high-volume production for applications such as unmanned systems and other emerging platforms. This contract highlights how the company's investments in scalable manufacturing and export-compliant infrared technology are being converted into sizeable, mission-focused orders across global markets. Now we’ll examine how this high-volume Tenum...

Centrus Energy stock has delivered a very large 5 year gain, yet the current valuation checks lean expensive, with the broader model assigning it a low overall value score. Over the past 5 years, Centrus Energy has returned about 5.5x, which sets a high bar for any further upside to be justified by fundamentals. Future cash generation from its enrichment and fuel-related activities can support the current share price, but any setback to margins or project timing may quickly pressure what...

Innodata previously announced it would release its second-quarter results on August 6, 2026, with an investor conference call scheduled for 5:00 PM Eastern to review the figures and discuss business progress. This timetable has sharpened attention on whether expectations for its AI and data services growth, and the valuation those expectations support, can withstand any sign of slower revenue momentum or profitability pressure. We’ll now examine how anticipation around the August earnings...

BeOne Medicines (ONC) is drawing investor attention after announcing plans to release its second quarter 2026 results on Wednesday, August 5, 2026, before markets open, followed by a management webcast. See our latest analysis for BeOne Medicines. BeOne Medicines' share price has risen 18.8% over the past month and 4.5% over the last week, while its 1 year total shareholder return of 5.9% and 3 year total shareholder return of around 5.8x suggest longer term holders have seen stronger...

Softer than expected inflation data prompted investors to reassess interest rate expectations, and United Bankshares (UBSI) moved higher alongside regional peers as markets evaluated the potential for relief on funding costs and loan demand. See our latest analysis for United Bankshares. At a share price of $47.58, United Bankshares has a 1 month share price return of 7.67% and a year to date share price return of 23.94%. The 1 year total shareholder return of 32.45% and 5 year total...

Celcuity stock has delivered a very large 3 year return, yet its recent pullback and a mixed set of valuation checks raise questions about how much of the good news around its newly approved breast cancer therapy is already reflected in the price. Over the last 3 years Celcuity has returned roughly 7x, which sets a high bar for further gains given how much value has already been created for existing shareholders. The full FDA approval of REVTORPYK for advanced HR positive, HER2 negative...

Karman Holdings stock has fallen 39.9% year to date, yet the valuation checks still lean expensive rather than pointing to a clear bargain. The share price is down 39.9% year to date, which puts the recent weakness front and center for anyone weighing up the current valuation. Growth projects such as expanded hypersonics, missile defense and space related capacity can support long term revenue expectations. However, heavier investment needs and execution risk may limit how much investors are...

Nurix Therapeutics, Inc. reported past second-quarter and six-month results to May 31, 2026, with revenue falling to US$9.04 million for the quarter and a net loss of US$89.54 million, and six-month revenue of US$15.30 million alongside a net loss of US$176.71 million. The widening basic loss per share from continuing operations, rising to US$0.81 for the quarter and US$1.60 for the half year, highlights growing cost pressures relative to sharply lower collaboration and operating...

Host Hotels & Resorts has delivered a 92.6% return over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks currently point to the stock trading at a discount to what its fundamentals may justify. That mix of strong long term performance and an apparent valuation gap is drawing attention to whether the current share price of US$23.94 still leaves room for further upside. The 92.6% five year return suggests long term shareholders in...

In recent days, Moelis has drawn attention as differing valuation models have painted contrasting pictures of the investment bank’s intrinsic worth, even as deal-making conditions remain supportive. This split between an Excess Returns model suggesting upside and earnings multiples implying a rich valuation has sharpened the focus on how dependent Moelis is on sustained merger and capital-raising activity. With analysts’ prior narrative built around expansion and earnings visibility, we’ll...

A. O. Smith (AOS) shares are in focus after the board reaffirmed a regular quarterly cash dividend of $0.36 per share, payable on August 17, 2026, to shareholders of record on July 31. See our latest analysis for A. O. Smith. At a latest share price of $58.85, A. O. Smith has seen the share price fall 13.86% year to date, while the 1 year total shareholder return is down 14.53%. This suggests momentum has been weakening despite the steady dividend. If this dividend announcement has you...

We wouldn't blame Arista Networks, Inc. ( NYSE:ANET ) shareholders if they were a little worried about the fact that...

With tech stocks under pressure and expectations running high this earnings season, some investors are looking more closely at areas of the market that can sometimes feel steadier when sentiment turns cautious. This defensive sectors screener focuses on consumer staples, health care, and real estate companies that meet certain size and quality criteria, and are directly exposed to the latest news around earnings surprises, guidance resets, and interest rate expectations. In this article, you...

Hercules Capital stock has returned 65.3% over the past 5 years. Yet today it trades at US$16.17, while the Excess Returns intrinsic value estimate and earnings-based multiples both point to an undervalued profile, raising the question of how much of that longer-term gain is backed by current fundamentals. The 65.3% return over 5 years suggests Hercules Capital has rewarded patient shareholders, so the key issue is whether the current valuation still leaves a margin of safety. The recent...

IQVIA Holdings (NYSE:IQV) executive Dr. Cynthia Verst testified before a U.S. House congressional subcommittee on modernizing early clinical development in the United States. The testimony focused on recommendations to improve regulatory engagement, research infrastructure, and the path from discovery to first in human studies. IQVIA Holdings, through its contract research and data analytics operations, sits close to the early stages of drug and device development. Dr. Verst’s appearance in...

Recently, Curbline Properties (CURB) received a Momentum Style Score of B and a Zacks Rank of #2, supported by analysts raising earnings estimates for the current and next fiscal years. This combination of upgraded projections and momentum ratings points to strengthening analyst confidence in Curbline’s operating trajectory relative to its retail REIT peers. Next, we’ll examine how these earnings estimate revisions could influence Curbline’s acquisition-led growth narrative and expectations...